Gila is focused on development of products to treat metabolic diseases in specific target populations.

Target Populations

Gila Therapeutics is developing products for two populations:

1 - Individuals with obesity or who are overweight and are trying to lose weight

Product lifecycle management may lead us to explore targeting the additional population of:

2 - Individuals who are trying to prevent weight gain


Available Approaches for Treating Obesity:

Available Treatment Options:

Clinicians treating obesity have found that no single therapy is completely efficacious.  Current options for treatment include:

  • Lifestyle changes / counseling
  • Pharmaceuticals
  • Devices
  • Surgery

Options for pharmaceutical treatments are limited by:

  • Unwanted side effects
  • Limited treatment durations

Despite these available treatments, there is an explosion of obesity worldwide, and hence there is need and opportunity for new and innovative treatments.


Product Strategy

  • Fill gaps in the current pharmaceutical options
  • Develop treatments based on recent discoveries by Gila’s founders
  • Demand achievable goals with clear paths to commercialization
  • Maintain strong Intellectual Property protection


Market Opportunity: The Obesity Epidemic

Obesity is This Century's Epidemic

  • Two thirds of the US population have obesity or are overweight; 80 million people suffer from obesity, while 120 million are classified as overweight (BMI of 25-30)
  • More than a billion people worldwide have obesity (BMI >30)
  • The associated co-morbidities cost the US healthcare system $190B every year
  • Obesity is a silent disease that impacts health, living costs and quality of life

Percent of Americans With Obesity:

(Data from Global Health Observatory data repository, WHO)


The prevalence of obesity is increasing worldwide:

Gila is pursuing a clearly identified, growing, and global market need.

Percentage of Population with Obesity, by Country

(Data from Global Health Observatory data repository, WHO)


Currently 108 million Americans are on diets, each making four to five attempts per year with only 1% success rate.

There is clearly a need for more and better solutions to address this growing epidemic.